Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SYNTARA LIMITED Call Transcript 2012

Apr 16, 2012

65830_rns_2012-04-16_a03210cf-4553-4af8-865d-ae67d9733640.pdf

Call Transcript

Open in viewer

Opens in your device viewer

Media Release

17 April 2012

==> picture [153 x 23] intentionally omitted <==

==> picture [153 x 24] intentionally omitted <==

PHARMAXIS QUARTERLY INVESTOR CONFERENCE CALL

Pharmaxis Ltd (PXS) will release its March 2012 Quarterly Report to Shareholders on the afternoon of Wednesday 18[th] April 2012. Pharmaxis CEO, Dr Alan Robertson, will host an investor teleconference the following morning to review the quarter and answer investor questions.

The teleconference will be on Thursday 19[th] April 2012 at 8.30am (Sydney time).

Telephone access (toll free):  Australia: 1800 838 758  USA/Canada: 1855 881 1339  UK: 0800 051 8245  NZ: 0800 446 958

Telephone access (metered): +61 2 9009 0730

Online access details are available on the Pharmaxis website home page at: www.pharmaxis.com.au

A recording of the conference will be available on the Pharmaxis website home page approximately 3 hours after the call.

SOURCE: Pharmaxis Ltd, Sydney, Australia CONTACT: Pharmaxis Investor Relations T: +61 2 9454 7200, F: +61 2 9451 3622, E: [email protected] Website: www.pharmaxis.com.au

Page 1 of 1